Skip to main content
Glama

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations declare readOnlyHint, openWorldHint, idempotentHint as true. Description adds critical behavioral context: parallel single call, SEC EDGAR/XBRL fetching, off-calendar fiscal year handling, sorting by primary metric, and citation URI return format.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

Description is a single dense paragraph. It front-loads examples and key points but could be slightly more structured for easier scanning. Still concise for the amount of information.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Input schema fully covered, no output schema but description mentions return format: paired data + citation URIs. All necessary information for an agent to use the tool correctly is present.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, and description enriches both parameters: 'type' enum with data origin details, 'values' with format (tickers vs drug names) and constraints (2-5 items).

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description explicitly states the tool performs side-by-side comparison of 2-5 companies or drugs, with example user phrases. It clearly distinguishes from sibling tools by indicating preference over sequential single-pack lookups.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

Provides explicit guidance: 'ALWAYS PREFER over sequential single-pack lookups when comparing entities.' Also explains when to use company vs drug types and how data is sourced.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

Try in Browser

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.9/5.0
Disambiguation3/5

Many tools serve overlapping purposes, such as the three ask_pipeworx variants (stable, beta, grounded) and the six Polymarket-specific tools. While detailed descriptions help distinguish them, an agent could still confuse bet_research with polymarket_edges or the ask_pipeworx versions.

Naming Consistency2/5

Naming is highly inconsistent: verb_noun (ask_pipeworx, compare_entities), noun_noun (bet_research, entity_profile), single verbs (forget, recall, search), and adjective_noun (recent_alerts, deep_research). No clear pattern emerges across the set.

Tool Count3/5

33 tools is on the high side for a server named 'Smithsonian' that actually covers a broad range of data sources (SEC, FDA, Polymarket, npm, etc.). The number feels borderline heavy but is still manageable if the server's true purpose is general research.

Completeness4/5

The tool set covers multiple domains (company financials, drugs, economics, prediction markets, npm, museum data) with reasonable depth. Minor gaps exist, such as lack of PyPI scanning or missing update/delete operations for some memory features, but core workflows are well-supported.